Blepharoptosis Clinical Trial
Official title:
Fibrin Sealant to Reduce Postoperative Bleeding After Blepharoplasty
This study is looking at the effect of Tisseel in eyelid surgery. Fibrin sealants (Tisseel) cause there to be less bleeding during surgery. Surgeons have used Tisseel for over two decades to reduce bruising. Ophthalmologists use it during surgery. Yet, there are no studies confirming the effect of Tisseel during eyelid surgery. Unpublished work suggests that it is effective in decreasing postoperative bruising. This study will confirm the effect of Tisseel on postoperative bruising in blepharoplasty.
The study is designed as a superiority randomized control trial. Tisseel will be used for hemostasis during the closure of one blepharoplasty incision. The side to receive Tisseel will be determined using a random number generator. After application of topical Tisseel, both eyelids will undergo standard blepharoplasty closure techniques. Pressure will be placed on both upper eyelids to mask the patient as to what side received the Tisseel. Postoperatively, patients will take photographs on postoperative days 1, 3, 7. Photographs with poor quality not allowing accurate assessment will not be scored and that visit will not be included in the study. The photographs will be assessed by two masked ophthalmic surgeons who will rate the degree of postoperative bruising. Upper and lower eyelids of each patient will be evaluated separately. Observers will assess each side for ecchymosis using a 10-point Likert scale (1, none; 10, severe) on postoperative days 1, 3 and 7. Given a blepharoplasty costs the healthcare system approximately $950 Canadian dollars, a vial of Tisseel ($160) would add approximately 17% to the cost (160/942.43 = 16.97%). Therefore, a 17% percent margin of superiority was used in power calculations to determine statistical efficacy of the intervention. A power calculation for a randomized control superiority trial was performed. A 17% percent margin of superiority was used in power calculations. These variable were used to calculate for a dichotomous outcome superiority trial. The calculated sample size was calculated to be 27 in each group. Tisseel is made from human plasma and may therefore contain infectious agents, such as viruses, that can cause disease. With over two decades of use, there has never been a reported case of hepatitis (HAV, HBV, HCV) or human immunodeficiency virus (HIV) transmission. However, Tisseel used during thoracic surgery has been associated with increased seropositivity for parvovirus B19. Although there were no complications associations with the parvovirus B19 infection observed, infection with parvo B19 can theoretically cause anemia or arthralgias, fifth disease in children, miscarriage, or rash. All patients who would be at risk of complications from such an infection were excluded. Research is ongoing, despite the continuation of the COVID-19 pandemic. Postoperative photographs taken by the patients are used to minimize contact during care. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00864656 -
Eyelid Position Interdependence in Involutional Ptosis Patients Submitted to 10% Phenylephrine
|
N/A | |
Recruiting |
NCT02959697 -
Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair
|
N/A | |
Recruiting |
NCT02501187 -
Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair
|
N/A | |
Completed |
NCT00793988 -
Vibration-Assisted Anaesthesia
|
Phase 4 | |
Completed |
NCT02367677 -
Digital Photographs to Evaluate Blepharoptosis
|
N/A | |
Recruiting |
NCT01239498 -
Saline Injection - Assisted Anesthesia in Eyelid Surgery
|
Phase 4 | |
Completed |
NCT01848041 -
Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
|
Phase 1/Phase 2 | |
Completed |
NCT01350024 -
Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid
|
N/A | |
Completed |
NCT06047418 -
Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
|
||
Active, not recruiting |
NCT03149367 -
Surgical Management of Blepharoptosis
|
N/A | |
Completed |
NCT03565887 -
Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
|
Phase 3 | |
Recruiting |
NCT01968174 -
Astigmatic Changes Secondary to Eyelid Surgeries
|
N/A | |
Completed |
NCT03536949 -
Study of Safety of RVL-1201 in Treatment of Blepharoptosis
|
Phase 3 | |
Active, not recruiting |
NCT04678115 -
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
|
N/A | |
Not yet recruiting |
NCT04235803 -
Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery
|
N/A | |
Completed |
NCT02988856 -
Magnetic Correction of Eye Lid Paralysis
|
N/A | |
Terminated |
NCT03239418 -
NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy
|
N/A | |
Not yet recruiting |
NCT02638610 -
Assessment of Changes of Periocular Skin Sensation Following Eyelid and Ocular Surface Surgeries
|
N/A | |
Enrolling by invitation |
NCT05945615 -
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
|
Phase 3 | |
Recruiting |
NCT06292182 -
Red Light Ptosis Proof-of-Concept
|
N/A |